Allred Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Allred Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,780	Closed	-$268K	–	445
2021 Q1	$268K	Buy	1,780 +25	+1%	+$3.97K	0.12%	158
2020 Q4	$265K	Hold	1,755	–	–	0.14%	147
2020 Q3	$237K	Buy	1,755 +125	+8%	+$17K	0.14%	142
2020 Q2	$222K	Buy	+1,630	New	+$208K	0.14%	142
2020 Q1	–	Sell	-450	Closed	-$54.2K	–	383
2019 Q4	$54.2K	Buy	+450	New	+$50.2K	0.03%	327

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Allred Capital Management's IBB Position: Q2 2021 in Review

Allred Capital Management sold out of iShares Biotechnology ETF (IBB) in Q2 2021, closing a stake of 1,780 shares — an estimated $268K sold.

Allred Capital Management first reported a position in IBB in Q4 2019 and held it in 5 quarters. The position peaked at $268K in Q1 2021. 863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

Allred Capital Management reported no remaining iShares Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
Allred Capital Management sold 1,780 iShares Biotechnology ETF shares in Q2 2021, an estimated $268K.
Allred Capital Management first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 5 quarters.
Allred Capital Management's iShares Biotechnology ETF position peaked at $268K in Q1 2021.
863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on Allred Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.